Press Releases
 
Lipid Disorder Treatment Market: Increased Chances of Cardiovascular Diseases to Drive the Demand

Lipid Disorder Treatment Market

, 10 August 2018 -- Global market for lipid disorder treatment is expected to grow at an exceptional pace during the period of assessment. This growth is fuelled by rising demand for modern lipid metabolism disorder treatments coupled with increased chances of cardiovascular diseases across the globe.The global market for lipid disorder treatment is poised to register a value CAGR of 7.4% during the period of assessment, 2017-2026

Market for lipid disorder treatment is largely influenced by growing incidences of disorders associated with LDL and increasing triglyceride level in human body. Lipid disorders are largely observed among working population across the globe, which is caused due to less body movements, unhealthy diets, absence of exercise and bad lifestyle habits such as drinking and excessive smoking that result in increasing bad cholesterol level. This has triggered the use of various drugs such as atorvastatin, fluvastatin or lescol, rosuvastatin and simvastatin to treat lipid disorders as they control and reduce the level of bad cholesterol and triglycerides in blood. The global market for lipid disorder treatment is witnessing increasing sales of these drugs, offering the manufacturers potential opportunities for development and distribution of these drugs in the coming years.

Read Report Overview @ https://www.transparencymarketresearch.com/lipid-disorder-treatment-market.html

The global lipid disorders market is expected to expand at an impressive rate, observes Transparency Market Research. The analysis on lipid disorders and their treatment reflects that the valuation of the global market is estimated to reach over US$ 40 Bn by the end of the year of assessment (2026). Growth of the global market is pushed by increasing developments in the treatment for lipid metabolism disorders. Companies involved in lipid disorder treatments are heavily investing in research and development of novel drugs to lower cholesterol levels thus reducing rate of lipid disorders. Companies involved in the global market include Pfizer, Inc., Novartis AG, Astrazeneca Plc,, Merck & Co., Emcure Pharmaceuticals Ltd., and Ranbaxy Laboratories Ltd.

Occurring within families due to genetic disorders, familial combined hyperlipidemia is the most common lipid disorder in which triglyceride level and plasma cholesterol is higher than normal and is the main cause of coronary diseases. The rate of incidence of this type of disorder is high among ######, whose treatment market has been a lucrative one for players involved in manufacturing of drugs for lipid disorders. Familial combined hyperlipidemia occurrence being at its peak, has pushed the use of various drugs for treating the disorder. The sale of drugs used in treating familial combined hyperlipidemia is higher than any other indication and is estimated to generate revenues worth US$ 15 Bn by end of assessment period. In addition, cases of familial defective apolipoprotein B-100 are also expected to generate significant revenues from drug sales in the coming years.

Request for the Sample Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=40640

Incidences of lipid disorders being high among world population, several pharmaceutical companies are focusing on developing advanced drugs for its treatment. Moreover, apart from increasing their production capacities, they are also concentrating on effective and speedy distribution of their drugs across regions. As per analysis, retail pharmacies are a distribution channel for sale of drugs. Moreover, being high in number worldwide, sale of drugs for lipid disorder treatment has increased considerably, with a major chunk coming from retail pharmacies. From this distribution channel, the sale value is estimated to reach more than US$ 20 Bn by 2026 end. Key players in the global lipid disorder treatment market can target retail pharmacies to increase their production profits and enhance their distribution network. Online pharmacy is another channel, expected to push the sales of drugs at a significant rate in the coming years

North America has been at the forefront with respect to increasing sale of drugs for lipid disorder treatment. This region possess high market attractiveness which can be attributed to increasing incidences of various lipid disorders and associated cardio vascular diseases. Manufacturers have been targeting this region by developing novel drugs to lower LDL content and treat lipid disorders and are heavily investing in the region, especially in United States. With respect to market value, North America surpasses other regions by reflecting higher sale of lipid disorder treatment which is estimated to exceed US$ 17 Bn by end of 2026.

Obtain the Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=40640

Atorvastatin drug is widely used for treating lipid disorders. The sale of this type of drug is higher owing to its effective action against bad cholesterol and other cardiovascular diseases. Production of atorvastatin is expected to increase in the coming years owing to its increasing preference among ###### as well as children who are at high risk in developing lipid disorders. Moreover, fluvastatin and rosuvastatin are also consumed at a significant rate for reducing triglyceride levels thus lowing risk of heart diseases

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us

Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
Website: https://www.transparencymarketresearch.com/

# # #


Submitted by hawer on Friday, 10 August 2018 at 3:20 PM
Category: Health Care & Medical
 
Related News

Fertility and Pregnancy Rapid Test Kits Market to Expand with Significant CAGR During 2025
Wednesday, 15 Aug 2018

Ways to Use Breast Enlargement Cream Successfully
Tuesday, 14 Aug 2018

Artificial Vital Organs and Medical Bionics Market to Garner Brimming Revenues by 2018
Tuesday, 14 Aug 2018

Scanning Probe Microscopes (SPM) Market to Expand Substantially Owing to Technological Innovations D
Tuesday, 14 Aug 2018

Hospital Beds Market to Register Substantial Expansion by 2026
Tuesday, 14 Aug 2018

Related Events

Hemophilia Drug Development
Tuesday, 14 Aug 2018

Rheumatology Board Review CME Conference - San Francisco 2018
Thursday, 16 Aug 2018

15th Annual Oncology Update CME Coverage of the 2018 ASCO Annual Meeting
Saturday, 18 Aug 2018

13th European Nitrogen Fixation Conference (ENFC)
Saturday, 18 Aug 2018

XXIII World Congress on Parkinson's Disease and Related Disorders
Sunday, 19 Aug 2018

Latest News

Variety Powersports, the best provider of top quality sports vehicles and accessories
Wednesday, 15 Aug 2018

Knotted Bamboo Skewers are Advantageous for Home Cooks, Caters and Restaurants
Wednesday, 15 Aug 2018

Normal Superphosphate Market Report 2024: By Product, Application, Manufacturer, Segmentation
Wednesday, 15 Aug 2018

Indium Oxide Market Overview, Dynamics and Trends, Segmentation 2024
Wednesday, 15 Aug 2018

Fire Resistant Glass Market Analysis and Forecast Study for 2016 - 2024
Wednesday, 15 Aug 2018

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2018
Today is Wednesday, 15 August 2018

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Hemophilia Drug Development
  • Sydney's Biggest Postgraduate Event - QS World Grad School Tour
  • Continuous Innovation of Sand Making Machine Technology
  • Summer NAPE
  • Palo Alto Networks: Ransomware's Next Steps

  • Latest Jobs
    Sorry, there are currently no entries posted here.